LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

Search

Microbot Medical Inc

Geschlossen

2.53 -3.07

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

2.51

Max

2.64

Schlüsselkennzahlen

By Trading Economics

Einkommen

791K

-2.6M

EPS

-0.08

Angestellte

20

EBITDA

-127K

-3.4M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+243.51% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

12. Aug. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

7.2M

100M

Vorheriger Eröffnungskurs

5.6

Vorheriger Schlusskurs

2.53

Technischer Score

By Trading Central

Vertrauen

Neutral Evidence

Microbot Medical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

21. Mai 2025, 23:25 UTC

Heiße Aktien

Stocks to Watch: Navitas Semiconductor, Urban Outfitters, Lumen Technologies, LiveRamp

21. Mai 2025, 21:57 UTC

Akquisitionen, Fusionen, Übernahmen

AT&T to Buy Lumen's Mass Markets Fiber Business for $5.75 Billion -- Update

21. Mai 2025, 21:29 UTC

Akquisitionen, Fusionen, Übernahmen

Millicom to Acquire Telefónica's Operations in Uruguay

21. Mai 2025, 21:01 UTC

Wichtige Markttreiber

Nvidia Selects Navitas Semiconductor to Work on Next-Generation 800V HVDC Architecture

21. Mai 2025, 23:49 UTC

Market Talk

Gold Edges Higher on Possible Investor Shift Away From Government Bonds -- Market Talk

21. Mai 2025, 23:37 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

21. Mai 2025, 23:33 UTC

Akquisitionen, Fusionen, Übernahmen

Vigil Neuroscience: Iluzanebart Return to Licensor Amgen to Occur Prior to Closing of Sanofi Deal

21. Mai 2025, 23:32 UTC

Akquisitionen, Fusionen, Übernahmen

Vigil Neuroscience Sees Sanofi Deal Strengthening Development Path for Oral Small Molecule TREM2 Agonist Program

21. Mai 2025, 23:32 UTC

Akquisitionen, Fusionen, Übernahmen

Vigil Neuroscience: Shareholders to Get Up to $10 a Share in Sanofi Deal >SAN.FR VIGL

21. Mai 2025, 23:32 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

James Hardie's Weak Update Spurs Questions Before AZEK Vote -- Market Talk

21. Mai 2025, 23:31 UTC

Akquisitionen, Fusionen, Übernahmen

Samsung Biologics: Remaining Entity to Focus on Contract Development & Manufacturing Organization Business

21. Mai 2025, 23:30 UTC

Akquisitionen, Fusionen, Übernahmen

Samsung Biologics: Spun-Off Entity Tentatively Named Samsung Episholdings

21. Mai 2025, 23:30 UTC

Akquisitionen, Fusionen, Übernahmen

Samsung Biologics: Separated Business Entity to Focus on R&D Affiliate Samsungbioepis, New Investment

21. Mai 2025, 23:29 UTC

Akquisitionen, Fusionen, Übernahmen

Samsung Biologics to Spin off R&D Segment Into Separate Holdings Company

21. Mai 2025, 23:28 UTC

Ergebnisse

Singtel to Finance Buybacks Via Excess Capital Generated From Asset Recycling >Z74.SG

21. Mai 2025, 23:27 UTC

Ergebnisse

Singtel Sets Up S$2.0B Share-Buyback Program >Z74.SG

21. Mai 2025, 23:26 UTC

Ergebnisse

Singtel: Net Rose Due to Exceptional Gain From Partial Divestment of Comcentre Headquarters >Z74.SG

21. Mai 2025, 23:26 UTC

Ergebnisse

Singtel FY25 Rev S$14.15B Vs. S$14.13B >Z74.SG

21. Mai 2025, 23:26 UTC

Ergebnisse

Singtel FY25 Net S$4.02B Vs. Net S$795.0M >Z74.SG

21. Mai 2025, 23:23 UTC

Akquisitionen, Fusionen, Übernahmen

Sanofi: VGL101, Vigil's Second Molecule Program, Isn't Being Acquired

21. Mai 2025, 23:22 UTC

Top News

Walmart to Cut 1,500 Corporate Jobs in Restructuring -- WSJ

21. Mai 2025, 23:22 UTC

Akquisitionen, Fusionen, Übernahmen

Sanofi Sees No Effect From Vigil Deal on 2025 Outlook >SAN.FR

21. Mai 2025, 23:20 UTC

Akquisitionen, Fusionen, Übernahmen

Sanofi: Vigil Deal Enhances Early-Stage Pipeline, Includes VG-3927, Which Will Be Evaluated in Alzheimer's Disease Study

21. Mai 2025, 23:18 UTC

Akquisitionen, Fusionen, Übernahmen

Sanofi to Buy Vigil Neuroscience for $8 a Share at Closing >SAN.FR VIGL

21. Mai 2025, 23:04 UTC

Top News

EV Owners Face Annual Fee Under Proposed Tax Bill -- Barrons.com

21. Mai 2025, 21:46 UTC

Top News

NBCUniversal Bids for MLB Rights That Were Dropped by ESPN -- WSJ

21. Mai 2025, 21:42 UTC

Top News
Akquisitionen, Fusionen, Übernahmen

AT&T to Buy Lumen's Mass Markets Fiber Business for $5.75B -- Update

21. Mai 2025, 21:14 UTC

Akquisitionen, Fusionen, Übernahmen

Millicom to Acquire Telefónica's Ops in Uruguay

21. Mai 2025, 21:07 UTC

Top News

NBCUniversal Bids for Major League Baseball Rights ESPN Dropped, Sources Say -- WSJ

21. Mai 2025, 21:06 UTC

Akquisitionen, Fusionen, Übernahmen

Uber Stock Is Dropping. Blame Elon Musk and Tesla. -- Barrons.com

Peer-Vergleich

Kursveränderung

Microbot Medical Inc Prognose

Kursziel

By TipRanks

243.51% Vorteil

12-Monats-Prognose

Durchschnitt 9 USD  243.51%

Hoch 9 USD

Tief 9 USD

Basierend auf 1 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Microbot Medical Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

1 ratings

1

Buy

0

Halten

0

Sell

Technischer Score

By Trading Central

2.52 / 2.57Unterstützung & Widerstand

Kurzfristig

Neutral Evidence

Mittelfristig

Very Strong Bullish Evidence

Langfristig

Weak Bullish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.